Pheburane 483 mg/g
Pheburane 483 mg/g is a medicine authorised by Swissmedic under authorisation number 67263. The authorisation holder is Medius AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 July 2020 and the authorisation is valid without a time limit. ATC code A16AX03 places the medicine in the group Other alimentary tract and metabolism products.
| Authorisation number | 67263 |
|---|---|
| Name | Pheburane 483 mg/g |
| Full name | Pheburane 483 mg/g, Granulat zur Herstellung einer Lösung zum Einnehmen |
| Authorisation holder | Medius AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A16AX03 |
| First authorisation | 29 July 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pheburane 483 mg/g, Granulat zur Herstellung einer Lösung zum Einnehmen | B | 29 July 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Flasche(n) | A16AX03 | 07.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Pheburane 483 mg/g authorised in Switzerland?
Yes. Pheburane 483 mg/g is authorised by Swissmedic under authorisation number 67263, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Pheburane 483 mg/g have?
Pheburane 483 mg/g is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Pheburane 483 mg/g?
The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.